Daedong Korea Ginseng대동고려삼

Daedong Korea Ginseng is a small KONEX-listed red ginseng maker with no financial statements in the data and a share price well below its 52-week high.

The company makes red ginseng products, concentrates and powders for domestic and overseas sale, plus ingredients for other health food makers. The data gives a share price of ₩1,799 and a market value of about ₩8.0B, but it contains no annual or trailing financial results, so current profitability cannot be assessed from the pack. Recent filings are mostly routine corporate actions, including a rights offering, dividend decisions and a shareholder meeting.

What stands out

• Share price is ₩1,799, up 3.4% over one month and 5.9% over three months, but down 14.1% over one year.
• The 52-week high is ₩2,840 and the 52-week low is shown as ₩0, which looks like a data gap rather than a real price.
• The data has no revenue, profit, or valuation multiples (P/E, P/B, EV/EBITDA) for this company, so its numbers cannot be compared with peers on that basis.
• The dividend yield is shown as 0%, and foreign ownership is recorded as 0% both now and 60 days ago.
• Filings from July to September 2026 include a rights offering decision and results, a cash dividend decision, the June 2026 annual report, and the AGM results. No news headlines are in the data.

What to watch

• The full annual report and audit report for June 2026, to see actual revenue, profit and cash flow, which are missing from this pack.
• Details of the rights offering (paid-in capital increase) and how it affects the share count and existing holders.
• Whether the company follows up its IR event and any further filings on dividends or shareholder matters.